BEUDAMED
    FDA Adverse Event Other Summary report: N

    CERNER

    MDR report key: 6136094 · Received November 15, 2016

    Report

    Report Number
    MW5066418
    Event Type
    Other
    Date Received
    November 15, 2016
    Report Date
    August 25, 2016
    Manufacturer
    CERNER
    Product Code
    OUG
    Report Source
    Voluntary report
    Reporter Occupation
    OTHER

    Narratives

    Description of Event or Problem · 1

    A (B)(6) FEMALE PT WAS BEING DISCHARGED FROM OUR HOSPITAL WITH PRESCRIPTION FOR ASPIRIN 40.5 MG CHEWABLE TABLET (1/2 OF 881 MG CHEWABLE TABLET). WE USE CERNER AT OUR FACILITY. THE DISCHARGE MEDICATION RECONCILIATION WAS DONE THROUGH CERNER AS IS OUR PROCESS, BUT THE DOSE OF THE DRUG DOES NOT TRANSMIT TO THE PT SUMMARY THAT IS PROVIDED TO THE PT. ONLY THE PRODUCT AND FREQUENCY TRANSMIT. THE DOSE DOES TRANSMIT TO ANY PRESCRIPTIONS BUT SINCE THAT WAS AN OVER THE COUNTER MEDICATION, THE PARENTS WERE USING THE PT SUMMARY TO KNOW WHAT TO GIVE THEIR CHILD. IT APPEARED ON THE PT SUMMARY THAT THE PT SHOULD RECEIVE THE ENTIRE 81 MG TABLET AS THEIR DOSE. THIS WAS CAUGHT BY THE PHYSICIAN BECAUSE THIS PARTICULAR PHYSICIAN HAD BEEN INVOLVED IN ANOTHER ERROR BECAUSE OF THIS SAME ISSUE. THE FAMILY WAS EDUCATED ON THE CORRECT DOSE TO ADMINISTER TO THEIR CHILD, BUT THE PT COULD HAVE RECEIVED A 50% INCREASE IN THE AMOUNT OF ASPIRIN THEY WERE SUPPOSED TO RECEIVE. MEDICATION ADMINISTERED TO OR USED BY THE PT: YES. WHERE DID THE ERROR OCCUR: HOSPITAL. (B)(6).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    755957 CERNER DEVICE DATA SYSTEM OUG CERNER

    Patients

    Seq Age Sex Outcome Treatment
    1 ASPIRIN CHEWABLE TABLET, ORAL 40.5 MG